Literature DB >> 17220907

The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.

M Tanabe1, Y Tokuda, K Takasu, K Ono, M Honda, H Ono.   

Abstract

BACKGROUND AND
PURPOSE: Exogenously administered thyrotropin-releasing hormone (TRH) is known to exert potent but short-acting centrally-mediated antinociceptive effects. We sought to investigate the mechanisms underlying these effects using the synthetic TRH analogue taltirelin, focusing on the descending monoaminergic systems in mice. EXPERIMENTAL APPROACH: The mice received systemic or local injections of taltirelin combined with either central noradrenaline (NA) or 5-hydroxytryptamine (5-HT) depletion by 6-hydroxydopamine (6-OHDA) or DL-p-chlorophenylalanine (PCPA), respectively, or blockade of their receptors. The degree of antinociception was determined using the tail flick and tail pressure tests. KEY
RESULTS: Subcutaneously (s.c.) administered taltirelin exhibited dose-dependent antinociceptive effects in the tail flick and tail pressure tests. These effects appeared to be primarily supraspinally mediated, since intracerebroventricularly (i.c.v.) but not intrathecally (i.t.) injected taltirelin generated similar effects. Depletion of central NA abolished only the analgesic effect of taltirelin (s.c. and i.c.v.) on mechanical nociception. By contrast, depletion of central 5-HT abolished only its analgesic effect on thermal nociception. Intraperitoneal (i.p.) and i.t. injection of the alpha2-adrenoceptor antagonist yohimbine respectively reduced the analgesic effect of taltirelin (s.c. and i.c.v.) on mechanical nociception. By contrast, the 5-HT1A receptor antagonist WAY-100635 (i.p. and i.t.) reduced the effect of taltirelin (s.c. and i.c.v.) on thermal nociception. Neither the 5-HT2 receptor antagonist ketanserin nor the opioid receptor antagonist naloxone altered the antinociceptive effect of taltirelin. CONCLUSIONS AND IMPLICATIONS: These findings suggest that taltirelin activates the descending noradrenergic and serotonergic pain inhibitory systems, respectively, to exert its analgesic effects on mechanical and thermal nociception.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220907      PMCID: PMC2189720          DOI: 10.1038/sj.bjp.0707125

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  65 in total

Review 1.  Descending noradrenergic influences on pain.

Authors:  S L Jones
Journal:  Prog Brain Res       Date:  1991       Impact factor: 2.453

2.  Effects of a new analog of thyrotropin-releasing hormone, N alpha-[(S)-4-oxo-2-azetidinyl) carbonyl]-L-histidyl-L-prolinamide dehydrate (YM-14673) on spinal reflex potentials and flexor reflexes in spinalized rats.

Authors:  H Ono; N Nagano; M Yamada; H Fukuda
Journal:  Neuropharmacology       Date:  1990-01       Impact factor: 5.250

3.  Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety.

Authors:  M Suzuki; H Sugano; K Matsumoto; M Yamamura; R Ishida
Journal:  J Med Chem       Date:  1990-08       Impact factor: 7.446

4.  Efficacy of thyrotropin-releasing hormone in the treatment of cerebellar ataxia.

Authors:  Y Takeuchi; K Fujiwara; K Ishimura; Y Shimada; M Ochi; H Yoshioka; T Sawada
Journal:  Pediatr Neurol       Date:  1989 Mar-Apr       Impact factor: 3.372

5.  Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.

Authors:  K C Fone; J V Johnson; G W Bennett; C A Marsden
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

6.  Opioid involvement in TRH-induced antinociception in the rat following intracerebral administration.

Authors:  V Reny-Palasse; C Monier; R Rips
Journal:  Pain       Date:  1989-08       Impact factor: 6.961

7.  Different role of 5-HT1A and 5-HT2 receptors in spinal cord in the control of nociceptive responsiveness.

Authors:  P K Eide; K Hole
Journal:  Neuropharmacology       Date:  1991-07       Impact factor: 5.250

8.  Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.

Authors:  M Yamamura; K Kinoshita; H Nakagawa; R Ishida
Journal:  Jpn J Pharmacol       Date:  1991-01

9.  Inhibition by thyrotropin-releasing hormone of epileptic seizures in spontaneously epileptic rats.

Authors:  H Ujihara; R M Xie; M Sasa; K Ishihara; Y Fujita; M Yoshimura; T Kishimoto; T Serikawa; J Yamada; S Takaori
Journal:  Eur J Pharmacol       Date:  1991-04-10       Impact factor: 4.432

10.  The apparent antinociceptive effect of desipramine and zimelidine in the tail flick test in rats is mainly caused by changes in tail skin temperature.

Authors:  Anders Lund; Arne Tjølsen; Kjell Hole
Journal:  Pain       Date:  1989-07       Impact factor: 6.961

View more
  11 in total

1.  The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system.

Authors:  K Nakamoto; T Nishinaka; N Sato; F Aizawa; T Yamashita; M Mankura; Y Koyama; F Kasuya; S Tokuyama
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 2.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

3.  The evolutionarily conserved transcription factor PRDM12 controls sensory neuron development and pain perception.

Authors:  Vanja Nagy; Tiffany Cole; Claude Van Campenhout; Thang M Khoung; Calvin Leung; Simon Vermeiren; Maria Novatchkova; Daniel Wenzel; Domagoj Cikes; Anton A Polyansky; Ivona Kozieradzki; Arabella Meixner; Eric J Bellefroid; G Gregory Neely; Josef M Penninger
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Involvement of spinal 5-HT1A receptors in isolation rearing-induced hypoalgesia in mice.

Authors:  Naotaka Horiguchi; Yukio Ago; Kazuki Asada; Yuki Kita; Naoki Hiramatsu; Kazuhiro Takuma; Toshio Matsuda
Journal:  Psychopharmacology (Berl)       Date:  2012-12-29       Impact factor: 4.530

5.  Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.

Authors:  James D Boghosian; Anita Luethy; Joseph F Cotten
Journal:  J Pharmacol Exp Ther       Date:  2018-04-19       Impact factor: 4.030

6.  Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor.

Authors:  Xin Zhao; Chuang Wang; Jun-Fang Zhang; Li Liu; Ai-Ming Liu; Qing Ma; Wen-Hua Zhou; Ying Xu
Journal:  Psychopharmacology (Berl)       Date:  2013-12-03       Impact factor: 4.530

7.  Excitation of locus coeruleus noradrenergic neurons by thyrotropin-releasing hormone.

Authors:  Hitoshi Ishibashi; Yoshihisa Nakahata; Kei Eto; Junichi Nabekura
Journal:  J Physiol       Date:  2009-10-19       Impact factor: 5.182

8.  Purpurin exerted antidepressant-like effects on behavior and stress axis reactivity: evidence of serotonergic engagement.

Authors:  Li Ma; Pei Hu; Junfang Zhang; Wugeng Cui; Xin Zhao
Journal:  Psychopharmacology (Berl)       Date:  2020-01-03       Impact factor: 4.530

9.  The antinociceptive effects of ferulic acid on neuropathic pain: involvement of descending monoaminergic system and opioid receptors.

Authors:  Ying Xu; Dan Lin; Xuefeng Yu; Xupei Xie; Liqun Wang; Lejing Lian; Ning Fei; Jie Chen; Naping Zhu; Gang Wang; Xianfeng Huang; Jianchun Pan
Journal:  Oncotarget       Date:  2016-04-12

10.  Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: engagement of spinal serotonergic system.

Authors:  Xin Zhao; Chuang Wang; Wu-Geng Cui; Qing Ma; Wen-Hua Zhou
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.